Skip to content

Effect of nebulized Budesonide on respiratory mechanics and oxygenation in patients with acute lung injury/acute respiratory distress syndrome: A prospective clinical study.

Effect of nebulized budesonide on respiratory mechanics and oxygenation in patients with acute lung injury/acute respiratory distress syndrome(ALI/ARDS).

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000373572
Enrollment
60
Registered
2015-04-23
Start date
2014-07-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We want to study the effect of nebulized budesonide on oxygenation and respiratory mechanics when used in conjunction with recruitment maneuver in patients with ALI/ARDS

Interventions

60 patients admitted to the ICU due to ALI/ARDS assigned to two groups:budesonide group(30 patients) where 1mg-2 ml budesonide suspension is nebulized through the endotracheal tube,while in the control group(30 patients) 2 ml isotonic saline is nebulized instead of budesonide.This regimen is applied twice daily for three successive days.Nebulization is performed using specific ventilator nebulized (Aeroneb pro-Aeroneb professional nebulized system Aerogen( Ireland) with an oxygen flow of 8 lite

60 patients admitted to the ICU due to ALI/ARDS assigned to two groups:budesonide group(30 patients) where 1mg-2 ml budesonide suspension is nebulized through the endotracheal tube,while in the control group(30 patients) 2 ml isotonic saline is nebulized instead of budesonide.This regimen is applied twice daily for three successive days.Nebulization is performed using specific ventilator nebulized (Aeroneb pro-Aeroneb professional nebulized system Aerogen( Ireland) with an oxygen flow of 8 liters/ min. The duration of each Nebulization session is 15 minutes. before each session, recruitment manoeuvre is done by increasing peak airway so as to get a plateau pressure of 30 cm. H2o for 30 seconds.

Sponsors

South valley university
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Patients should fulfill the criteria of ALI/ARDS according to 2012 Berlin definition of ALI/ARDS

Exclusion criteria

Refusal of consent by relatives,age <18 or>65 years,chronic obstructive pulmonary disears,restrictive respiratory insufficiency,increased intracranial pressure, bronchpleural fistula,acute myocardial infarction and neuromuscular disease.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 27, 2026